Morgan Stanley Maintains Underweight on Lazard, Lowers Price Target to $41

Benzinga · 1d ago
Morgan Stanley analyst Ryan Kenny maintains Lazard (NYSE:LAZ) with a Underweight and lowers the price target from $44 to $41.